Skip to main content

Tower Research Capital LLC (TRC)

Position in CADL — Candel Therapeutics, Inc.

CIK 1533421 NEW YORK, NY

Position in CADL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$14,606
+$3,990 QoQ
Shares Held
2,981
+58.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Tower Research Capital LLC (TRC) holds $67,724,931 across 440 Biotechnology names. CADL ranks #257 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CADL

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $14,606 2,981
2025-12-31 $10,616 1,879
2025-09-30 $28,723 5,632
2025-06-30 $48,616 9,608
2025-03-31 $11,757 2,081
2024-12-31 $12,646 1,457
2024-09-30 $18,960 2,736
2024-06-30 $7,762 1,252
2024-03-31 $5,849 3,702
2023-12-31 $9,897 6,733
2023-09-30 $7,955 8,647
2023-06-30 $10,410 8,262
2023-03-31 $8,877 6,576
2022-12-31 $12,913 7,214
2022-09-30 $12,990 4,137
2022-06-30 $3,949 1,219
2022-03-31 $274 54